| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.3M | -50.1% |
| R&D Expense | $54.2M | -9.0% |
| SG&A Expense | $32.2M | -8.7% |
| Operating Income | -$52.1M | -99.3% |
| Pre-tax Income | -$45.7M | -738.0% |
| Income Tax | $0 | — |
| Net Income | -$45.7M | -738.0% |
| EPS (Basic) | -$3.56 | -439.0% |
| EPS (Diluted) | -$3.56 | -442.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.8M | +29.0% |
| Short-term Investments | $4.8M | +1053.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $118.7M | +25.0% |
| Total Assets | $154.4M | +13.2% |
| Current Liabilities | $8.9M | -40.5% |
| Total Liabilities | $62.2M | -22.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.8M | -12.7% |
| Investing Cash Flow | -$634K | -194.9% |
| Financing Cash Flow | $95.2M | +88.6% |
| $92.2M |
| +63.6% |